World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
84317
World Ranking
12876
National Ranking
6584

David J. Gordon publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where David J. Gordon sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 261 publications — 10th percentile

10% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

David J. Gordon D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where David J. Gordon sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 88 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

David J. Gordon is affiliated with the University of Iowa in the United States. Their research spans primarily across the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with notable contributions in the subfields of Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cardiology and Cardiovascular Medicine, and Surgery.

The research topics covered in their work include:

  • Sarcoma Diagnosis and Treatment
  • Protein Degradation and Inhibitors
  • Ubiquitin and proteasome pathways
  • Acute Myeloid Leukemia Research
  • Cancer-related Molecular Pathways
  • RNA modifications and cancer
  • Histone Deacetylase Inhibitors Research

David J. Gordon has published in several scientific journals with recurring appearances in the following venues:

  • arXiv (Cornell University)
  • Journal of the American College of Cardiology
  • International Journal of Molecular Sciences
  • Oncogene
  • Cancer Research Communications

Frequent collaborators in their scholarly work include:

  • Stacia L. Koppenhafer
  • Rebecca D. Dodd
  • Dawn E. Quelle
  • William W. Terry
  • Lei Zhao

Selected recent papers authored or co-authored by David J. Gordon include:

  • "CDKs in Sarcoma: Mediators of Disease and Emerging Therapeutic Targets," 2020, International Journal of Molecular Sciences
  • "The translational repressor 4E-BP1 regulates RRM2 levels and functions as a tumor suppressor in Ewing sarcoma tumors," 2020, Oncogene
  • "Disruption of dNTP homeostasis by ribonucleotide reductase hyperactivation overcomes AML differentiation blockade," 2022, Blood
  • "Eltrombopag inhibits the proliferation of Ewing sarcoma cells via iron chelation and impaired DNA replication," 2020, BMC Cancer
  • "Outcomes of male patients with HR+/HER2- advanced breast cancer receiving palbociclib in the real-world POLARIS study," 2023, Breast Cancer Research and Treatment

Best Publications

  • Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement.

    Scott M Grundy;James I. Cleeman;Stephen R. Daniels;Karen A. Donato

  • 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

    Neil J Stone;Jennifer G Robinson;Alice H. Lichtenstein;C Noel Bairey Merz

  • Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)

    Curt D. Furberg;Jackson T. Wright;Barry R Davis;Jeffrey A. Cutler

  • High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.

    D. J. Gordon;J. L. Probstfield;R. J. Garrison;Jim Neaton

  • Diagnosis and management of the metabolic syndrome

    Scott M Grundy;James I. Cleeman;Stephen R. Daniels;Karen A. Donato

  • High-Density Lipoprotein — The Clinical Implications of Recent Studies

    David J. Gordon;Basil M. Rifkind

  • Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary.

    Scott M. Grundy;James I. Cleeman;Stephen R. Daniels;Karen A. Donato

  • Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer The Women's Health Study: A Randomized Controlled Trial

    I-Min Lee;Nancy R. Cook;J. Michael Gaziano;David Gordon

  • Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease

    Manson Je;Cook Nr;Lee Im;Christen W

  • Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans

    Gary J. Nabel;Elizabeth G. Nabel;Zhi Yong Yang;Bernard A. Fox

  • Low-Dose Aspirin in the Primary Prevention of Cancer: The Women’s Health Study: A Randomized Controlled Trial

    Nancy R. Cook;I-Min Lee;J. Michael Gaziano;David Gordon

  • Causes and consequences of aneuploidy in cancer

    David J. Gordon;Benjamin Resio;David Pellman

  • Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer

    Manson Je;Cook Nr;Lee Im;Christen W

  • T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo.

    L A Turka;P S Linsley;H Lin;W Brady

  • Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion.

    Hua Lin;Steven F. Bolling;Peter S. Linsley;Ru Qi Wei

  • The Effects of Nonpharmacologic Interventions on Blood Pressure of Persons With High Normal Levels: Results of the Trials of Hypertension Prevention, Phase I

    Paul K. Whelton;Lawrence Appel;Jeanne Charleston;Arlene Taylor Dalcin

  • Rationale and Design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

    Barry R Davis;Jeffrey A. Cutler;David J. Gordon;Curt D. Furberg

  • Decline in Cardiovascular Mortality: Possible Causes and Implications

    George A. Mensah;Gina S. Wei;Paul D. Sorlie;Lawrence J. Fine

  • Trends in serum lipids and lipoproteins of adults, 1960-2002.

    Margaret D. Carroll;David A. Lacher;Paul D. Sorlie;James I. Cleeman

  • Vitamin D supplements and prevention of cancer and cardiovascular disease

    Manson Je;Cook Nr;Lee Im;Christen W

Frequent Co-Authors

Elizabeth G. Nabel
Elizabeth G. Nabel Brigham and Women's Hospital
Gary J. Nabel
Gary J. Nabel ModeX Therapeutics
Zhi-Yong Yang
Zhi-Yong Yang ModeX Therapeutics LLC
Stephen C. Meredith
Stephen C. Meredith University of Chicago
Carl J. Pepine
Carl J. Pepine University of Florida
Jeffrey L. Probstfield
Jeffrey L. Probstfield University of Washington
Nancy R. Cook
Nancy R. Cook Brigham and Women's Hospital
Curt D. Furberg
Curt D. Furberg Wake Forest University
Lemuel A. Moyé
Lemuel A. Moyé The University of Texas Health Science Center at Houston
Julie E. Buring
Julie E. Buring Brigham and Women's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Not everyone wishing to build a career in healthcare chooses the traditional MD pathway. Many students opt for alternative or supporting roles, which can be pursued through flexible and affordable online degrees. For example, those looking for entry into nursing might consider a 9 month lpn program, which allows you to start working as a Licensed Practical Nurse quickly.

For those interested in advanced practice, pursuing the fastest psych np program can provide a pathway to becoming a Psychiatric Mental Health Nurse Practitioner, a high-demand specialty.

Healthcare leadership roles are also accessible through online study. Finding the cheapest online healthcare administration degree is an excellent option for those keen on management and administrative positions. Similarly, exploring the cheapest online mha programs helps graduates advance to higher-level management roles in the healthcare sector.

Whether you aim for clinical practice or administrative expertise, these online degree options offer flexibility, affordability, and varied career paths in U.S. healthcare.

Best Scientists Citing David J. Gordon

Trending Scientists

Recently Published Articles